AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Sorrento Therapeutics, Inc.

$0.00 -$0.00 (-90.48%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00$0.01
Year Range
$0.00$0.01
Market Cap
165.38K
AVG Volume
263.11K
Trailing/Forward PE
-0/0
PEG ratio
-0
Dividend Yield
-
Next Earnings Date
2026-11-06
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
020M40M60M80M21 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Revenue (USD) by quarter, trailing twelve months
PeriodRevenue (USD)
23 Q264.27M
23 Q160.71M
22 Q462.84M
22 Q360.32M
22 Q254.98M
22 Q157.03M
21 Q452.9M
21 Q351.33M
21 Q251.02M
21 Q146.52M
Net Income (USD) · TTM
-800M-600M-400M-200M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Net Income (USD) by quarter, trailing twelve months
PeriodNet Income (USD)
23 Q2-549.21M
23 Q1-673.54M
22 Q4-574.74M
22 Q3-495.47M
22 Q2-524.58M
22 Q1-471.65M
21 Q4-428.32M
21 Q3-355.41M
21 Q2-319.63M
21 Q1-230.75M
Operating Income (USD) · TTM
-600M-400M-200M021 Q121 Q221 Q321 Q422 Q122 Q222 Q322 Q423 Q123 Q2
SRNE Operating Income (USD) by quarter, trailing twelve months
PeriodOperating Income (USD)
23 Q2-463.35M
23 Q1-478M
22 Q4-478.53M
22 Q3-413.72M
22 Q2-393.84M
22 Q1-402.51M
21 Q4-380.53M
21 Q3-346.24M
21 Q2-339.08M
21 Q1-286.26M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (USD) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: SRNE

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 6 Nov 2026.

Sorrento Therapeutics, Inc.
SRNE
Stockpicker

Video analysis: SRNE

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: SRNE

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.